• [[Translated article]]Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient
• [Translated article] Acquired Epidermodysplasia Verruciformis in a Solid Organ Transplant Recipient
• [Translated article] Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases
• [Translated article] Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient
• A Case of Hypopigmented Macules in Scalp of Children with Obvious Improvement to Topical Retinoid: Epidermodysplasia Verruciformis or Clear Cell Papulosis?
• A novel EVER1 gene mutation associated with epidermodysplasia verruciformis and multiple cutaneous malignancies
• A novel EVER1 polymorphism of epidermodysplasia verruciformis: Homozygous TMC6 c.718del
• A Novel Homozygous RHOH Variant Associated with T Cell Dysfunction and Recurrent Opportunistic Infections
• A Novel Large Deletion in the EVER1 Gene in a Family With Epidermodysplasia Verruciformis From India
• A TMC8 splice variant causes epidermodysplasia verruciformis in a Pakistani family
• Acitretin Treatment Improves a Case of Severe Generalized Epidermodysplasia Verruciformis
• Acquired epidermodysplasia verruciformis (AEV) in three children after cardiac transplantation: A case series and review of the literature
• Acquired Epidermodysplasia Verruciformis During Highly Active Antiretroviral Therapy
• Acquired epidermodysplasia verruciformis in a renal transplant patient: a case report
• Acquired Epidermodysplasia Verruciformis in a Solid Organ Transplant Recipient
• Acquired Epidermodysplasia Verruciformis in a Solid Organ Transplant Recipient
• Acquired epidermodysplasia verruciformis secondary to methotrexate
• Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review
• Acquired epidermodysplasia verruciformis: a review of cases with long-term follow-up
• Acquired epidermodysplasia verruciformis: a therapeutic challenge
• Aggressive Squamous Cell Carcinoma in a Case of Epidermodysplasia Verruciformis Carrying a TMC6 Splice-site Mutation
• Case of epidermodysplasia verruciformis with a novel mutation of TMC8
• Case Report: Altered NK Cell Compartment and Reduced CXCR4 Chemotactic Response of B Lymphocytes in an Immunodeficient Patient With HPV-Related Disease
• Clear Cell Porocarcinoma Arising in an Epidermodysplasia Verruciformis Patient
• Clinical guideline for the diagnosis and treatment of cutaneous warts (2022)
• Clinical spectrum of DOCK8 deficiency from a tertiary care center in North India
• Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India
• Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21
• Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases
• Congenital Epidermodysplasia Verruciformis in Skin of Color: New Dermoscopic Features
• Cutaneous squamous cell carcinoma in vertically acquired HIV and epidermodysplasia verruciformis
• Defects of the Innate Immune System and Related Immune Deficiencies
• Deficiency in <em>Ever2</em> does not increase susceptibility of mice to pathogenesis by the mouse papillomavirus, MmuPV1
• Diffuse skin-colored papules in a child
• Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient
• Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed Human Papillomavirus Type 8‒Transgenic Mice
• Eosinophilic homogeneous intracytoplasmic inclusion bodies in acquired epidermodysplasia verruciformis-like lesions
• Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49
• Epidermodysplasia Verruciformis
• Epidermodysplasia Verruciformis
• Epidermodysplasia Verruciformis and Breast Cancer - Casual or Causal?
• Epidermodysplasia Verruciformis and Vdelta2 gammadelta T-cell Expansion in STK4 Deficiency
• Epidermodysplasia verruciformis arising in a female with systemic lupus erythematosus: a rare case from Syria
• Epidermodysplasia Verruciformis in CADINS Disease: Expanding the Phenotype
• Epidermodysplasia Verruciformis in Fitzpatrick Skin Type VI: New Dermoscopic Findings
• Epidermodysplasia verruciformis in Mohs micrographic surgery
• Epidermodysplasia verruciformis mimicking pityriasis versicolor
• Epidermodysplasia verruciformis or tree-man
• Epidermodysplasia verruciformis with squamous cell carcinomas and the identification of a novel TMC8 mutation
• Epidermodysplasia verruciformis-associated eccrine neoplasm: a rare entity with distinctive clinical and histopathologic features
• Epidermodysplasia Verruciformis-Report of Familial Occurrence and a Rare Association with Eccrine Porocarcinoma
• Epidermodysplasia Verruciformis: A Study of Clinicopathologic Features, Biomarkers, and Associated Malignancies in Indian Patients
• Establishment of a human induced pluripotent stem cell line, KMUGMCi005-A, from a patient with Epidermodysplasia verruciformis (EV) bearing homozygous splicing donor site mutation in the TMC8 gene
• Eyelid squamous cell carcinoma in the setting of epidermodysplasia verruciformis (EV) diagnosed by next-generation sequencing: A case report and literature review
• Focal epidermodysplasia-verruciformis-like pathologic changes in skin neoplasms
• High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression
• HPV-57 Verruca Vulgaris Mimicking Epidermodysplasia Verruciformis
• HPV-Related Skin Phenotypes in Patients with Inborn Errors of Immunity
• Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis
• Human Papillomavirus
• Human Papillomavirus
• Human Papillomavirus (Nursing)
• Human Papillomavirus (Nursing)
• Invasive SCC and Tirbanibulin: Experience in Patient With Epidermodysplasia Verruciformis
• Is It EDV?: Diffuse Hypopigmented Keratosis vs Epidermodysplasia Verruciformis: Similar yet Different Entities
• Lepromatous leprosy in a case of epidermodysplasia verruciformis - A coincidence or a result of defective cell-mediated immunity?
• Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review
• Multicentric Castleman disease in a DOCK8-deficient patient with Orf virus infection
• Multimodal Treatment of Epidermodysplasia Verruciformis in an HIV-Positive Man
• Multiple recurrent cutaneous squamous cell carcinomas in situ secondary to epidermodysplasia verruciformis: A case report and successful treatment with aminolevulinic acid photodynamic therapy
• Nonpruritic hypopigmented macules on an immunocompromised patient
• Possible ruxolitinib-induced acquired epidermodysplasia verruciformis and multiple non-melanoma skin cancers in a patient with polycythemia vera
• Recalcitrant Warts, Epidermodysplasia Verruciformis, and the Tree-Man Syndrome: Phenotypic Spectrum of Cutaneous Human Papillomavirus Infections at the Intersection of Genetic Variability of Viral and Human Genomes
• Recent advances in cutaneous HPV infection
• Recurrent fungating tumor and a chronic rash in an immunosuppressed transgender patient: a case of Buschke-Lowenstein condyloma and epidermodysplasia verruciformis
• RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer
• Seborrheic Keratosis Caused by Human Papillomavirus Type 20 Ameliorated by Zinc Oxide Ointment
• Squamous Cell Carcinoma Arising From Epidermodysplasia Verruciformis
• Squamous cell lung carcinoma in a patient with epidermodysplasia verruciformis
• Stefania Jabłońska (1920-2017): A giant in 20^th century dermatology
• STK4 deficiency and epidermodysplasia verruciformis-like lesions: A case report
• Successful treatment of epidermodysplasia verruciformis with a combination of 5-aminolevulinic acid photodynamic therapy and surgery
• Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Vaccination in a Kidney Transplant Recipient
• Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient
• Synchronous Epidermodysplasia Verruciformis and Intraepithelial Lesion of the Vulva Is Caused by Coinfection With Alpha-Human Papillomavirus and Beta-Human Papillomavirus Genotypes and Facilitated by Mutations in Cell-Mediated Immunity Genes
• Tattoo-Associated Viral Infections: A Review
• The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPalpha/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesions
• The HPV8 E6 protein targets the Hippo and Wnt signaling pathways as part of its arsenal to restrain keratinocyte differentiation
• The role of HPV in keratinocyte skin cancer development: A systematic review
• The transmembrane channel-like 6 (TMC6) in primary sensory neurons involving thermal sensation via modulating M channels
• Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells
• Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes
• Unveiling the Therapeutic Horizon: HPV Vaccines and Their Impact on Cutaneous Diseases-A Comprehensive Review
• Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice
• Verruca Vulgaris Occurring on a Tattoo: Case Report and Review of Tattoo-Associated Human Papillomavirus Infections
• Viral infections and inborn errors of immunity
• Wart
• Wart
• Whole transcriptome-based skin virome profiling in typical epidermodysplasia verruciformis reveals alpha-, beta-, and gamma-HPV infections
• Whole transcriptome-based skin virome profiling in typical epidermodysplasia verruciformis reveals α-, β-, and γ-HPV infections